Guggenheim Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,692
| Closed | -$437K | – | 2136 |
|
|
2021
Q3 | $437K | Buy |
+7,692
| New | +$437K | ﹤0.01% | 1796 |
|
|
2018
Q4 | – | Sell |
-13,699
| Closed | -$1.17M | – | 2220 |
|
|
2018
Q3 | $1.17M | Buy |
13,699
+2,576
| +23% | +$220K | 0.01% | 1529 |
|
|
2018
Q2 | $1.29M | Sell |
11,123
-42,096
| -79% | -$4.88M | 0.01% | 1488 |
|
|
2018
Q1 | $4.31M | Buy |
53,219
+43
| +0.1% | +$3.48K | 0.01% | 1105 |
|
|
2017
Q4 | $3.12M | Buy |
53,176
+25,413
| +92% | +$1.49M | 0.01% | 1329 |
|
|
2017
Q3 | $1.3M | Buy |
27,763
+1,605
| +6% | +$75K | ﹤0.01% | 1938 |
|
|
2017
Q2 | $942K | Sell |
26,158
-1,402
| -5% | -$50.5K | ﹤0.01% | 2109 |
|
|
2017
Q1 | $848K | Sell |
27,560
-2,990
| -10% | -$92K | ﹤0.01% | 2183 |
|
|
2016
Q4 | $1.02M | Buy |
+30,550
| New | +$1.02M | ﹤0.01% | 2127 |
|
|
2016
Q3 | – | Sell |
-36,718
| Closed | -$809K | – | 2895 |
|
|
2016
Q2 | $809K | Buy |
36,718
+5,118
| +16% | +$113K | ﹤0.01% | 2178 |
|
|
2016
Q1 | $928K | Buy |
31,600
+11,919
| +61% | +$350K | ﹤0.01% | 2102 |
|
|
2015
Q4 | $650K | Sell |
19,681
-31,122
| -61% | -$1.03M | ﹤0.01% | 2315 |
|
|
2015
Q3 | $1.84M | Buy |
50,803
+12,740
| +33% | +$460K | 0.01% | 1653 |
|
|
2015
Q2 | $1.71M | Sell |
38,063
-7,132
| -16% | -$321K | ﹤0.01% | 1889 |
|
|
2015
Q1 | $1.38M | Buy |
45,195
+4,869
| +12% | +$149K | ﹤0.01% | 2064 |
|
|
2014
Q4 | $2.05M | Sell |
40,326
-165,062
| -80% | -$8.4M | 0.01% | 1719 |
|
|
2014
Q3 | $8.13M | Buy |
205,388
+192,691
| +1,518% | +$7.63M | 0.02% | 970 |
|
|
2014
Q2 | $562K | Buy |
+12,697
| New | +$562K | ﹤0.01% | 2509 |
|